Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence
Sterilizing immunity after vaccination is desirable to prevent the spread of infection from
vaccinees, which can be especially dangerous in hospital settings while managing frail …
vaccinees, which can be especially dangerous in hospital settings while managing frail …
Approaches and challenges in SARS-CoV-2 vaccine development
The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this
global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster …
global pandemic. Progress in SARS-CoV-2 vaccine development to date has been faster …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …
The evolution of poxvirus vaccines
After Edward Jenner established human vaccination over 200 years ago, attenuated
poxviruses became key players to contain the deadliest virus of its own family: Variola virus …
poxviruses became key players to contain the deadliest virus of its own family: Variola virus …
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
Most pathogens initiate their infections at the human mucosal surface. Therefore, mucosal
vaccination, especially through oral or intranasal administration routes, is highly desired for …
vaccination, especially through oral or intranasal administration routes, is highly desired for …
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
L Moreno-Fierros, I García-Silva… - Expert Opinion on …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by the SARS-CoV-2 virus is having an unprecedented
impact on global health derived from its quick spread, which is attributed to its high stability …
impact on global health derived from its quick spread, which is attributed to its high stability …
Enhancing poxvirus vectors vaccine immunogenicity
Attenuated recombinant poxvirus vectors expressing heterologous antigens from pathogens
are currently at various stages in clinical trials with the aim to establish their efficacy. This is …
are currently at various stages in clinical trials with the aim to establish their efficacy. This is …
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
The coronavirus disease 2019 (COVID-19) pandemic requires the continued development
of safe, long-lasting, and efficacious vaccines for preventive responses to major outbreaks …
of safe, long-lasting, and efficacious vaccines for preventive responses to major outbreaks …
An insight into current treatment strategies, their limitations, and ongoing developments in vaccine technologies against herpes simplex infections
D Sharma, S Sharma, N Akojwar, A Dondulkar… - Vaccines, 2023 - mdpi.com
Herpes simplex virus (HSV) infection, the most prevalent viral infection that typically lasts for
a lifetime, is associated with frequent outbreaks of oral and genital lesions. Oral herpes …
a lifetime, is associated with frequent outbreaks of oral and genital lesions. Oral herpes …
AT cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
S Boulton, J Poutou, R Gill, N Alluqmani, X He… - … Therapy-Methods & …, 2023 - cell.com
SARS-CoV-2, the etiological agent behind the coronavirus disease 2019 (COVID-19)
pandemic, has continued to mutate and create new variants with increased resistance …
pandemic, has continued to mutate and create new variants with increased resistance …